{"nct_id":"NCT02955069","title":"Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)","status":"COMPLETED","status_verified_date":"2021-03","start_date":"2017-02-14","start_date_type":"ACTUAL","primary_completion_date":"2018-08-10","primary_completion_date_type":"ACTUAL","completion_date":"2020-05-13","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}